Valneva is a specialty vaccine company focused on the development, manufacturing and commercialization of prophylactic vaccines for infectious diseases. Our strategy is based on an integrated business model that has allowed us to build a portfolio of differentiated clinical and pre-clinical assets as well as a robust commercial portfolio.
The Company held an analyst call on Monday, November 13, 2023.View More
Investor Relations TeamCampus Bio-Ouest
6, Rue Alain Bombard
44800 Saint-Herblain, France T: +33 2 28 07 37 10 email@example.com
Subscribe to Valneva News